About Culmination Bio
Culmination Bio is a company based in St. George (United States) founded in 2022. Culmination Bio has raised $10 million across 1 funding round from investors including Amgen and Merck Global Health Innovation Fund. The company has 1 employees as of December 31, 2021. Culmination Bio offers products and services including Culmination Intelligence Platform and Novel Clinical Insights. Culmination Bio operates in a competitive market with competitors including Litmus Health, BioRun, Avacare, ASR Sciences and Center Point Clinical Services, among others.
- Headquarter St. George, United States
- Employees 1 as on 31 Dec, 2021
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Culmination, Inc.
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$10 M (USD)
in 1 rounds
-
Latest Funding Round
$10 M (USD), Series A
Nov 30, 2023
-
Investors
Amgen
& 1 more
-
Employee Count
1
as on Dec 31, 2021
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Culmination Bio
Culmination Bio offers a comprehensive portfolio of products and services, including Culmination Intelligence Platform and Novel Clinical Insights.
Provides clinical data and biospecimens for research and health insights.
Generates insights from multi-modal data for therapeutic development.
People of Culmination Bio
Unlock access to complete
Funding Insights of Culmination Bio
Culmination Bio has successfully raised a total of $10M through 1 strategic funding round. The most recent funding activity was a Series A round of $10 million completed in November 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Culmination Bio
Culmination Bio has secured backing from 2 investors, including venture fund and institutional investors. Prominent investors backing the company include Amgen and Merck Global Health Innovation Fund.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Corporate-backed venture capital is focused on the life science sector.
|
Locked | Locked | Locked | |
|
Developer of pharmaceutical products for treating multiple diseases
|
Locked | Locked | Locked |
Investor details for Culmination Bio
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Culmination Bio
Investment portfolio details for Culmination Bio
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Culmination Bio
Detailed financials for Culmination Bio
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Culmination Bio Comparisons
Peer comparison for Culmination Bio
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Culmination Bio
Culmination Bio operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Litmus Health, BioRun, Avacare, ASR Sciences and Center Point Clinical Services, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Data from wearables is leveraged for clinical trial decisions.
|
|
| Locked | Locked | Locked |
Gene function research and applications are focused on by BioRun.
|
|
| Locked | Locked | Locked |
Provides clinical trial management services for sponsors, sites, and patients globally.
|
|
| Locked | Locked | Locked |
Provides bio-analytical and clinical development services for the biopharmaceutical sector.
|
|
| Locked | Locked | Locked |
Offers siteless CRO and pharmacist-led solutions for clinical trials management.
|
Detailed competitors of Culmination Bio
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Culmination Bio
Complete news archive for Culmination Bio
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Culmination Bio
Culmination Bio was founded in 2022 and raised its 1st funding round 1 year after it was founded.
Culmination Bio is headquartered in St. George, United States. It is registered at St. George, Utah, United States.
Culmination Bio is a funded company, having raised a total of $10M across 1 funding round to date.
As of Dec 31, 2021, the latest employee count at Culmination Bio is 1.
Culmination Bio was established in 2022 and is headquartered in St. George, United States. Operations center on the biotechnology sector, where novel therapeutics for various applications are advanced through development stages. Clinical data services are also managed, supporting research and trial processes for pharmaceutical partners. The companys domain, culmination.com, facilitates access to these specialized offerings in the therapeutics and data management fields.
Culmination Bio's top competitors include Litmus Health, LB Research and BioRun.
Culmination Bio offers Culmination Intelligence Platform and Novel Clinical Insights.
Culmination Bio has 2 investors. Key investors include Amgen, and Merck Global Health Innovation Fund.